田忠林,李季泓,张凤芹,赵克明
TIAN Zhong-lin,LI Ji-hong,ZHANG Feng-qin,ZHAO Ke-ming

• 1:辽宁中医药大学附属医院药学部
• 2:辽宁中医药大学附属医院呼吸科

摘要(Abstract)：

目的研究槲寄生碱对非小细胞肺癌H358细胞的抑制作用及其相关作用机制。方法采用MTT法检测槲寄生碱对H358细胞增殖的抑制作用;采用流式细胞仪检测槲寄生碱对H358细胞凋亡的影响;采用Western blot方法检测槲寄生碱对K-Ras、Bcl-2和Bax等蛋白表达的影响;测定caspase 3、caspase 8和caspase 9的活性;检测槲寄生碱在体内的抑瘤活性。结果槲寄生碱以质量浓度依赖的方式抑制H358细胞增殖,并能有效地诱导H358细胞凋亡;caspase 3、caspase 8和caspase 9受到了不同程度的激活;同时,槲寄生碱抑制K-Ras和Bcl-2的表达,而对Bax没有明显抑制作用;槲寄生碱在体内也表现出明显的抑瘤活性。结论槲寄生碱在体外能够抑制H358细胞增殖并诱导H358细胞凋亡,为K-Ras突变型非小细胞肺癌等肿瘤疾病的治疗奠定了实验基础。
Objective To observe the inhibitory effect of mistletoe alkali on H358 cells and to investigate the relevant molecular mechanism. Methods The inhibitory effect of mistletoe alkali on H358 cells was determined by MTT method. The apoptosis of H358 cells was determined by flowcytometry. The activity of caspase 3,caspase 8 and caspase 9 was determined by using caspase activity assay kit. The protein expression level of K-Ras,Bcl-2 and Bax was determined by Western blot method. Results It was shown that mistletoe alkali could inhibit the proliferation of H358 cells in dose-dependent manner both in vitro and in vivo. It could induce the apoptosis of H358 cells. The activity of caspase 3,8,9 in H358 cells was increased while the expression of K-Ras and Bcl-2 was decreased with the increase of mistletoe alkali concentration. But the expression of Bax had no change. Conclusions Mistletoe alkali can inhibit the proliferation of H358 cells in vitro and in vivo.

关键词(KeyWords)： 槲寄生碱;H358细胞;细胞凋亡;K-Ras抗体
mistletoe alkali;H358 cell;cell apoptosis;K-Ras antibody

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 田忠林,李季泓,张凤芹,赵克明
TIAN Zhong-lin,LI Ji-hong,ZHANG Feng-qin,ZHAO Ke-ming

DOI: 10.14066/j.cnki.cn21-1349/r.2017.05.009

参考文献(References)：

• [1]黄冬生,李军.姜黄素对人肺癌细胞凋亡相关蛋白Survivin表达的影响[J].临床肺科杂志,2009,14(6):723-724.
• [2]李亚娟,周洪澜,葛岩,等.槲寄生碱对人腺样囊性癌细胞的抑制作用[J].吉林大学学报(医学版),2008,34(4):601-604.
• [3]廖翔宇.槲寄生碱对人肺腺癌A549细胞抑制作用的实验研究[D].长春:吉林大学,2008.
• [4]章永红,彭海燕.槲寄生碱的制法及其在制备治疗癌症药物中的应用:1417208A[P].2003-05-14.
• [5]HORVITZ H R.Genetic control of programmed cell death in the nematode Caenorhabditis elegans[J].Cancer Research,1999,59(4):1701-1706.
• [6]JACOBSON M D,WEIL M,RAFF M C.Programmed cell death in animal development[J].Cell,1997,88(3):347-354.
• [7]ADAMS J M,CORY S.The Bcl-2 apoptotic switch in cancer development and therapy[J].Oncogene,2007,26(9):1324-1337.
• [8]LOWE S W,CEPERO E,EVAN G.Intrinsic tumour suppression[J].Nature,2004,432(432):307-315.
• [9]EVAN G,LITTLEWOOD T.A matter of life and cell death[J].Science,1998,281(5381):1317-1322.
• [10]SOPHONNITHIPRASERT T,MAHABUSARAKAM W,NAKAMURA Y,et al.Antiproliferation and apoptosis induction in colorectal cancer cells by goniothalamin[J].Journal of the National Medical Association,2015,98(Suppl 9):146-151.
• [11]GABRIEL I,STEPHEN W G.A fate worse than death:apoptosis as an oncogenic process[J].Nature Reviews Cancer,2016,16(8):539-548.
• [12]JOHNSTONE R W,RUEFLI A A,LOWE S W.Apoptosis:a link between cancer genetics and chemotherapy[J].Cell,2002,108(2):153-164.
• [13]SHI Y.Mechanism of Caspase activation and inhibition during apoptosis[J].Molecular Cell,2002,9(3):459-470.
• [14]KRAMMER P H.CD95's deadly mission in the immune system[J].Nature,2000,407(6805):789-795.
• [15]TONG Z,LIU N,LIN L,et al.miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2,BCL2L12 and MCL1[J].Biomed Pharmacother,2015,75(1):129-136.
• [16]VERVLIET T,PARYS J B,BULTYNCK G.Bcl-2 proteins and calcium signaling:complexity beneath the surface[J].Oncogene,2016,10(9):5079-5092.
• [17]RUSNAK D W,AFFLECK K,COCKERILL S G,et al.The characterization of novel,dual Erb B22/EGFR,tyrosine kinase inhibitors:potential therapy for cancer[J].Cancer Research,2001,61(19):71-96.
• [18]YU L Y,PVLAYEVA G,ELDA G,et al.RAS oncogenes:weaving a tumorigenic web[J].Nature Reviews Cancer,2011,11(11):761-774.